TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
This Quarter Return
-0.55%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.51B
AUM Growth
+$111M
Cap. Flow
+$219M
Cap. Flow %
14.5%
Top 10 Hldgs %
37.54%
Holding
194
New
40
Increased
63
Reduced
17
Closed
11

Sector Composition

1 Healthcare 94.65%
2 Technology 1.65%
3 Communication Services 1.35%
4 Consumer Discretionary 0.56%
5 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
APGE icon
76
Apogee Therapeutics
APGE
$2.27B
$4.53M 0.3%
100,000
LNTH icon
77
Lantheus
LNTH
$3.75B
$4.47M 0.3%
50,000
BDTX icon
78
Black Diamond Therapeutics
BDTX
$164M
$4.43M 0.29%
2,070,209
+700,000
+51% +$1.5M
RVMD icon
79
Revolution Medicines
RVMD
$7.43B
$4.37M 0.29%
+100,000
New +$4.37M
MRUS icon
80
Merus
MRUS
$5.04B
$4.21M 0.28%
100,000
PHAT icon
81
Phathom Pharmaceuticals
PHAT
$843M
$4.06M 0.27%
+500,000
New +$4.06M
NUVL icon
82
Nuvalent
NUVL
$5.74B
$3.91M 0.26%
50,000
ARE icon
83
Alexandria Real Estate Equities
ARE
$13.9B
$3.9M 0.26%
40,000
CMPS
84
Compass Pathways
CMPS
$452M
$3.78M 0.25%
+1,000,000
New +$3.78M
IOVA icon
85
Iovance Biotherapeutics
IOVA
$800M
$3.7M 0.24%
500,000
TECX
86
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$3.66M 0.24%
79,166
GRAL
87
GRAIL, Inc. Common Stock
GRAL
$1.17B
$3.57M 0.24%
+200,000
New +$3.57M
STOK icon
88
Stoke Therapeutics
STOK
$1.08B
$3.31M 0.22%
+300,000
New +$3.31M
HRTX icon
89
Heron Therapeutics
HRTX
$204M
$3.27M 0.22%
2,140,271
+290,271
+16% +$444K
CCCC icon
90
C4 Therapeutics
CCCC
$182M
$3.24M 0.21%
900,000
+200,000
+29% +$720K
FATE icon
91
Fate Therapeutics
FATE
$115M
$3.06M 0.2%
1,855,954
+1,155,954
+165% +$1.91M
TGTX icon
92
TG Therapeutics
TGTX
$5.03B
$3.01M 0.2%
100,000
CRBP icon
93
Corbus Pharmaceuticals
CRBP
$119M
$2.86M 0.19%
242,653
-357,347
-60% -$4.22M
SWTX
94
DELISTED
SpringWorks Therapeutics
SWTX
$2.68M 0.18%
74,265
ELEV
95
DELISTED
Elevation Oncology
ELEV
$2.68M 0.18%
4,760,000
JANX icon
96
Janux Therapeutics
JANX
$1.38B
$2.68M 0.18%
+50,000
New +$2.68M
DTIL icon
97
Precision BioSciences
DTIL
$59.5M
$2.57M 0.17%
673,332
+50,000
+8% +$191K
OKUR
98
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$2.53M 0.17%
294,626
TBPH icon
99
Theravance Biopharma
TBPH
$692M
$2.47M 0.16%
262,896
ATYR
100
aTyr Pharma
ATYR
$560M
$2.43M 0.16%
671,134